Global Regulatory Affairs Services
Menu
About
Services
CMC
Regulatory
Quality
Pharmaceutical Development
Due Diligence
Project Management
Corporate Solutions
Contact
Regulatory
Draft and review of CTD sections for global submissions
Module 2 (2.3.QOS)
Module 3 (3.2.S, 3.2.P, 3.2.A and 3.2.R)
Review of all “attached” documents associated or submitted with Module 3
Paper and/or electronic filing
INDs/IMPDs/CTAs and amendments
Marketing Application (NDAs, BLAs, MAAs)
Variations
Major variations (Prior-Approval Submissions, Type II, MAV…)
Minor variations (CBE30, Type IA, Type IB, MIV…)
Notifications (CBE0, Type IAIN…)
Annual reports
DMFs/ASMFs
Briefing books
Meeting with Health Agencies (Preparation, meeting minutes).
Our Services
CMC
Regulatory
Quality
Pharmaceutical Development
Due Diligence
Project Management
Corporate Solutions